对比增强乳腺X线摄影:弥合研究空白并定义未来方向
本文综述对比增强乳腺X线摄影(CEM)在技术、安全性、判读和临床应用方面的主要研究空白,涉及采集方案、对比剂剂量和背景实质强化判读的标准化,比较CEM与乳腺MRI的诊断性能,并讨论CEM引导活检、高危女性补充筛查及人工智能与影像组学整合等新应用。
要点
- CEM通过双能乳腺X线摄影和静脉碘对比剂同时提供形态学与功能信息
- CEM的采集方案、对比剂剂量和背景实质强化判读等关键环节仍需标准化
- CEM引导活检和高危女性补充筛查等新应用及人工智能整合正在探索中
核心结论
- CEM临床应用日益增多,但其实施方式仍不统一,多个技术和临床问题尚未解决。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告。
诊断标准与关键数值
- 原文未报告CEM诊断性能的具体敏感度、特异度、AUC或阈值。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- CEM的实施仍不统一,若干技术和临床问题尚未得到解答。
- 采集方案、对比剂剂量和背景实质强化判读等关键领域有待标准化。
- 辐射暴露和对比剂反应等安全性问题有待解决。
- CEM与乳腺MRI诊断性能的比较有待明确。
- CEM引导活检和高危女性补充筛查等新应用有待进一步评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Contrast-enhanced mammography (CEM) has emerged as a promising breast imaging technique offering morphological and functional information through the use of dual-energy mammography and intravenous iodinated contrast agents. Despite increasing clinical use, its implementation remains heterogeneous, and several technical and clinical questions stay unanswered. This review aims to highlight the major research gaps related to CEM technique, safety, interpretation, and clinical applications. We examined key areas requiring standardization, including acquisition protocols, contrast agent dosing, and interpretation of background parenchymal enhancement. Safety concerns regarding radiation exposure and contrast media reactions were addressed, along with a comparison between CEM and breast MRI in terms of diagnostic performance. New applications such as CEM-guided biopsies and supplemental screening in high-risk women were critically reviewed and the integration of artificial intelligence and radiomics into CEM interpretation was also considered and discussed. Finally, we briefly summarized the main ongoing multicenter trials investigating the clinical utility and implementation of CEM across different healthcare settings.
引用
- Pediconi F, Moffa G. Contrast-Enhanced Mammography: Bridging the research gaps and defining the future. Eur J Radiol. 2025. PMID: 40848522. doi:10.1016/j.ejrad.2025.112351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。